Acne cream aims to shrink oil glands in new study
NCT ID NCT06425900
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a cream called clascoterone (Winlevi) can shrink oil glands and change the oil on the face in people with acne. Ten adults with oily skin and moderate acne will use the cream twice daily for 3 months. Researchers will take small skin samples to see if the glands get smaller and if the oil's makeup changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- clascoterone cream 1%
- What this could lead to
- If it works, this could point toward a treatment that reduces acne by shrinking oil glands and changing oil composition.
- What could go wrong
- This is a very small early-phase trial with only 10 participants, so results may not apply to everyone. It also requires ongoing cream use, not a one-time fix.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dermatology Consulting Services, PLLC
High Point, North Carolina, 27262, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentle cream outperform harsh acne drugs?
- Can acne drug harm the eyes? new study investigates
- A new serum aims to clear acne and boost skin confidence
- Head-to-Head: which acne cream works better for clear skin?
- Acne Treatment's Oil-Reducing power put to the test
- AI writes acne guide, students score same as human version